GT Biopharma Inc (GTBP)
3.21
-0.09
(-2.73%)
USD |
NASDAQ |
May 06, 16:00
3.21
0.00 (0.00%)
After-Hours: 19:47
GT Biopharma Free Cash Flow (Quarterly): -2.047M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.047M |
| September 30, 2023 | -1.964M |
| June 30, 2023 | -1.935M |
| March 31, 2023 | -2.906M |
| December 31, 2022 | -4.298M |
| September 30, 2022 | -2.918M |
| June 30, 2022 | -2.786M |
| March 31, 2022 | -5.215M |
| December 31, 2021 | -3.705M |
| September 30, 2021 | -3.929M |
| June 30, 2021 | -4.288M |
| March 31, 2021 | -3.684M |
| December 31, 2020 | -1.927M |
| September 30, 2020 | -1.701M |
| June 30, 2020 | -3.411M |
| March 31, 2020 | -0.223M |
| December 31, 2019 | -0.485M |
| September 30, 2019 | -1.126M |
| June 30, 2019 | -1.087M |
| March 31, 2019 | -0.961M |
| December 31, 2018 | -1.276M |
| September 30, 2018 | -3.435M |
| June 30, 2018 | -1.774M |
| March 31, 2018 | -4.228M |
| December 31, 2017 | -2.152M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.237M |
| June 30, 2017 | -0.391M |
| March 31, 2017 | -0.65M |
| December 31, 2016 | -0.135M |
| September 30, 2016 | -0.563M |
| June 30, 2016 | -1.065M |
| March 31, 2016 | -0.167M |
| December 31, 2015 | -0.944M |
| September 30, 2015 | -0.633M |
| June 30, 2015 | -1.293M |
| March 31, 2015 | -1.787M |
| December 31, 2014 | -1.038M |
| September 30, 2014 | -0.578M |
| June 30, 2014 | -0.043M |
| March 31, 2014 | -0.09M |
| December 31, 2013 | -0.369M |
| September 30, 2013 | 0.045M |
| June 30, 2013 | 0.02M |
| March 31, 2013 | -0.138M |
| December 31, 2012 | -0.214M |
| September 30, 2012 | -0.278M |
| June 30, 2012 | -0.303M |
| March 31, 2012 | -0.192M |
| December 31, 2011 | -0.324M |
| September 30, 2011 | -0.099M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.215M
Minimum
Mar 2022
-0.223M
Maximum
Mar 2020
-2.612M
Average
-2.786M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Cutera Inc | -36.37M |
| Outlook Therapeutics Inc | -13.03M |
| 180 Life Sciences Corp | -2.16M |
| Journey Medical Corp | -16.52M |
| NovaBay Pharmaceuticals Inc | -0.316M |